Homepage > Company > Media > Pharma News > 2021 > EU targets vaccine production capacity of 2-3 billion doses/year by end-2021 paper

EU targets vaccine production capacity of 2-3 billion doses/year by end-2021 paper

MILAN (Reuters) - The European Union aims to increase the region’s COVID-19 vaccine production capacity to 2-3 billion doses per year by the end of 2021, Industry Commissioner Thierry Breton was quoted as saying on Wednesday.

In an interview with Italian daily Corriere della Sera he also urged member states to implement their vaccination policies quickly “because the capacity to produce doses is increasing from week to week”, he said.

Breton said that while around 43 million doses have been delivered to the EU so far, only 30.2 million have been administered, adding the bloc was targeting deliveries of 95-100 million doses by the end of March.

February 4, 2021

https://www.reuters.com/

Read also

UK and US agree on landmark pharma pricing tariff deal

The UK and US have agreed to keep tariffs on UK pharmaceutical shipments into the US at zero.

Parkinson's drug as basis for new anti-infectives

Pseudomonas aeruginosa – one of the most common hospital germs – has sophisticated mechanisms to efficiently infect the human body and evade the immune system or antibiotics.

Modified herpes virus helps destroy glioblastoma in preclinical models

Researchers at Mass General Brigham have modified a herpes simplex virus (HSV-1) that stimulates the immune system to attack glioblastoma cells.

Curi Bio: $10 Million Series B Closed To Scale Human-Relevant Preclinical Platforms

Curi Bio has secured a $10 million Series B round led by Seoul-based contract research organization DreamCIS, funding that will accelerate the expansion of the company’s integrated human-relevant pr...